Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2543663rdf:typepubmed:Citationlld:pubmed
pubmed-article:2543663lifeskim:mentionsumls-concept:C0006675lld:lifeskim
pubmed-article:2543663lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:2543663lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:2543663lifeskim:mentionsumls-concept:C0851827lld:lifeskim
pubmed-article:2543663lifeskim:mentionsumls-concept:C1701901lld:lifeskim
pubmed-article:2543663lifeskim:mentionsumls-concept:C2744539lld:lifeskim
pubmed-article:2543663pubmed:issue3lld:pubmed
pubmed-article:2543663pubmed:dateCreated1989-7-18lld:pubmed
pubmed-article:2543663pubmed:abstractTextFour monoclonal antibodies to human thrombomodulin were characterized. Binding of two of these antibodies was dependent on the presence of calcium ions, and approximately 5 mM calcium was required for their maximum binding. These two antibodies inhibited the binding of thrombin to thrombomodulin, thereby inhibiting activation of protein C catalyzed by thrombin-thrombomodulin complex. These two antibodies bind to a major active fragment formed by limited proteolytic digestions of thrombomodulin with elastase and trypsin, suggesting that the antibodies bind to the thrombin-binding site (or its vicinity) located in the epidermal growth factor (EGF)-homology domain. One of the other calcium-independent antibodies also inhibited the binding of thrombin and the activation of protein C, but the inhibition was very weak and was observed only when the antibody was present in a molar excess over thrombomodulin. This antibody did not bind to the protease digests of thrombomodulin. Another calcium-independent antibody did not inhibit either thrombin binding or protein C activation, but bound to the active fragment of protease digests, suggesting that the antibody binds to a region other than the thrombin-binding site in the EGF-homology domain. These observations suggest that thrombomodulin undergoes a calcium-dependent conformational change which may occur in proximity to a thrombin-binding site located in the EGF-homology domain.lld:pubmed
pubmed-article:2543663pubmed:languageenglld:pubmed
pubmed-article:2543663pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2543663pubmed:citationSubsetIMlld:pubmed
pubmed-article:2543663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2543663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2543663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2543663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2543663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2543663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2543663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2543663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2543663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2543663pubmed:statusMEDLINElld:pubmed
pubmed-article:2543663pubmed:monthMarlld:pubmed
pubmed-article:2543663pubmed:issn0021-924Xlld:pubmed
pubmed-article:2543663pubmed:authorpubmed-author:KimuraSSlld:pubmed
pubmed-article:2543663pubmed:authorpubmed-author:AokiNNlld:pubmed
pubmed-article:2543663pubmed:authorpubmed-author:NagoyaTTlld:pubmed
pubmed-article:2543663pubmed:issnTypePrintlld:pubmed
pubmed-article:2543663pubmed:volume105lld:pubmed
pubmed-article:2543663pubmed:ownerNLMlld:pubmed
pubmed-article:2543663pubmed:authorsCompleteYlld:pubmed
pubmed-article:2543663pubmed:pagination478-83lld:pubmed
pubmed-article:2543663pubmed:dateRevised2007-12-19lld:pubmed
pubmed-article:2543663pubmed:meshHeadingpubmed-meshheading:2543663-...lld:pubmed
pubmed-article:2543663pubmed:meshHeadingpubmed-meshheading:2543663-...lld:pubmed
pubmed-article:2543663pubmed:meshHeadingpubmed-meshheading:2543663-...lld:pubmed
pubmed-article:2543663pubmed:meshHeadingpubmed-meshheading:2543663-...lld:pubmed
pubmed-article:2543663pubmed:meshHeadingpubmed-meshheading:2543663-...lld:pubmed
pubmed-article:2543663pubmed:meshHeadingpubmed-meshheading:2543663-...lld:pubmed
pubmed-article:2543663pubmed:meshHeadingpubmed-meshheading:2543663-...lld:pubmed
pubmed-article:2543663pubmed:meshHeadingpubmed-meshheading:2543663-...lld:pubmed
pubmed-article:2543663pubmed:meshHeadingpubmed-meshheading:2543663-...lld:pubmed
pubmed-article:2543663pubmed:meshHeadingpubmed-meshheading:2543663-...lld:pubmed
pubmed-article:2543663pubmed:meshHeadingpubmed-meshheading:2543663-...lld:pubmed
pubmed-article:2543663pubmed:meshHeadingpubmed-meshheading:2543663-...lld:pubmed
pubmed-article:2543663pubmed:meshHeadingpubmed-meshheading:2543663-...lld:pubmed
pubmed-article:2543663pubmed:meshHeadingpubmed-meshheading:2543663-...lld:pubmed
pubmed-article:2543663pubmed:meshHeadingpubmed-meshheading:2543663-...lld:pubmed
pubmed-article:2543663pubmed:meshHeadingpubmed-meshheading:2543663-...lld:pubmed
pubmed-article:2543663pubmed:meshHeadingpubmed-meshheading:2543663-...lld:pubmed
pubmed-article:2543663pubmed:meshHeadingpubmed-meshheading:2543663-...lld:pubmed
pubmed-article:2543663pubmed:year1989lld:pubmed
pubmed-article:2543663pubmed:articleTitleMonoclonal antibodies to human thrombomodulin whose binding is calcium dependent.lld:pubmed
pubmed-article:2543663pubmed:affiliationTokyo Research Institute, Kowa Ltd.lld:pubmed
pubmed-article:2543663pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2543663lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2543663lld:pubmed